"Improving health care for urologic patients in Greater Los Angeles Area, treating male and female Urologic issues."

During the past decade, Urology Group of Southern California conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology Group of Southern California" #1 sponsor was "Ferring Pharmaceuticals" with 1 trials, followed by "Pfizer" with 1 trials sponsored, "TesoRx Pharma, LLC" with 1 trials sponsored, "UroGen Pharma Ltd." with 1 trials sponsored and "Urovant Sciences GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Urology Group of Southern California" are "Overactive Bladder" (2 trials), "Bladder Cancer" (1 trials), "Hypogonadism" (1 trials), "Superficial Bladder Cancer" (1 trials) and "Urinary Bladder, Overactive" (1 trials). Many other conditions were trialed in "Urology Group of Southern California" in a lesser frequency.

Most popular intervention types in "Urology Group of Southern California" are "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Desmopressin orally disintegrating tablets" (1 trials), "EG-70" (1 trials), "Fesoterodine 8 mg" (1 trials), "Placebo" (1 trials) and "Placebo orally disintegrating tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Group of Southern California" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Urology Group of Southern California". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Urology Group of Southern California, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urology Group of Southern California, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".